-
Something wrong with this record ?
Hemorrhage and Recurrence of Obliterated Brain Arteriovenous Malformations Treated With Stereotactic Radiosurgery
CJ. Chen, D. Ding, JS. Kumar, KN. Kearns, N. Ironside, HC. Yang, A. Ogino, H. Kano, R. Liscak, J. May, BJ. Williams, MJ. Gigliotti, K. Cockroft, J. McInerney, S. Simon, CC. Lee, JP. Sheehan, International Radiosurgery Research Foundation
Language English Country United States
Document type Journal Article
NLK
Free Medical Journals
from 1970 to 1 year ago
Open Access Digital Library
from 1970-01-01
Open Access Digital Library
from 1970-01-01
- MeSH
- Child MeSH
- Intracranial Arteriovenous Malformations * diagnostic imaging radiotherapy surgery MeSH
- Intracranial Hemorrhages etiology MeSH
- Humans MeSH
- Brain pathology MeSH
- Follow-Up Studies MeSH
- Radiosurgery * adverse effects MeSH
- Retrospective Studies MeSH
- Treatment Outcome MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Publication type
- Journal Article MeSH
BACKGROUND: Although complete nidal obliteration of brain arteriovenous malformations (AVM) is generally presumed to represent durable cure, postobliteration hemorrhage, and AVM recurrence have become increasingly recognized phenomena. The goal of the study was to define hemorrhage and nidal recurrence risks of obliterated AVMs treated with stereotactic radiosurgery (SRS). METHODS: This is a retrospective cohort study from the International Radiosurgery Research Foundation comprising AVM patients treated between 1987 and 2020. Patients with AVM obliteration on digital subtraction angiography (DSA) were included. Outcomes were (1) hemorrhage and (2) AVM recurrence. Follow-up duration began at the time of AVM obliteration and was censored at subsequent hemorrhage, AVM recurrence, additional AVM treatment, or loss to follow-up. Annualized risk and survival analyses were performed. A sensitivity analysis comprising patients with AVM obliteration on magnetic resonance imaging or DSA was also performed for postobliteration hemorrhage. RESULTS: The study cohort comprised 1632 SRS-treated patients with AVM obliteration on DSA. Pediatric patients comprised 15% of the cohort, and 42% of AVMs were previously ruptured. The mean imaging follow-up after AVM obliteration was 22 months. Among 1607 patients with DSA-confirmed AVM obliteration, 16 hemorrhages (1.0%) occurred over 2223 patient-years of follow-up (0.72%/y). Of the 1543 patients with DSA-confirmed AVM obliteration, 5 AVM recurrences (0.32%) occurred over 2071 patient-years of follow-up (0.24%/y). Of the 16 patients with postobliteration hemorrhage, AVM recurrence was identified in 2 (12.5%). In the sensitivity analysis comprising 1939 patients with post-SRS AVM obliteration on magnetic resonance imaging or DSA, 16 hemorrhages (0.83%) occurred over 2560 patient-years of follow-up (0.63%/y). CONCLUSIONS: Intracranial hemorrhage and recurrent arteriovenous shunting after complete nidal obliteration are rare in AVM patients treated with SRS, and each phenomenon harbors an annual risk of <1%. Although routine postobliteration DSA cannot be recommended to SRS-treated AVM patients, long-term neuroimaging may be advisable in these patients.
Department of Neurological Surgery University of Pittsburgh Medical Center PA
Department of Neurological Surgery University of Virginia Health System Charlottesville
Department of Neurosurgery Na Homolce Hospital Prague Czech Republic
Department of Neurosurgery Neurological Institute Taipei Veterans General Hospital Taiwan
Department of Neurosurgery Penn State Health Hershey Medical Center Hershey PA
Department of Neurosurgery The University of Texas Health Science Center at Houston
Department of Neurosurgery University of Louisville KY
School of Medicine National Yang Ming University Taipei Taiwan
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22025122
- 003
- CZ-PrNML
- 005
- 20221031101253.0
- 007
- ta
- 008
- 221017s2022 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1161/STROKEAHA.122.039213 $2 doi
- 035 __
- $a (PubMed)35616021
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Chen, Ching-Jen $u Department of Neurosurgery, The University of Texas Health Science Center at Houston (C.-J.C.) $1 https://orcid.org/0000000278309273
- 245 10
- $a Hemorrhage and Recurrence of Obliterated Brain Arteriovenous Malformations Treated With Stereotactic Radiosurgery / $c CJ. Chen, D. Ding, JS. Kumar, KN. Kearns, N. Ironside, HC. Yang, A. Ogino, H. Kano, R. Liscak, J. May, BJ. Williams, MJ. Gigliotti, K. Cockroft, J. McInerney, S. Simon, CC. Lee, JP. Sheehan, International Radiosurgery Research Foundation
- 520 9_
- $a BACKGROUND: Although complete nidal obliteration of brain arteriovenous malformations (AVM) is generally presumed to represent durable cure, postobliteration hemorrhage, and AVM recurrence have become increasingly recognized phenomena. The goal of the study was to define hemorrhage and nidal recurrence risks of obliterated AVMs treated with stereotactic radiosurgery (SRS). METHODS: This is a retrospective cohort study from the International Radiosurgery Research Foundation comprising AVM patients treated between 1987 and 2020. Patients with AVM obliteration on digital subtraction angiography (DSA) were included. Outcomes were (1) hemorrhage and (2) AVM recurrence. Follow-up duration began at the time of AVM obliteration and was censored at subsequent hemorrhage, AVM recurrence, additional AVM treatment, or loss to follow-up. Annualized risk and survival analyses were performed. A sensitivity analysis comprising patients with AVM obliteration on magnetic resonance imaging or DSA was also performed for postobliteration hemorrhage. RESULTS: The study cohort comprised 1632 SRS-treated patients with AVM obliteration on DSA. Pediatric patients comprised 15% of the cohort, and 42% of AVMs were previously ruptured. The mean imaging follow-up after AVM obliteration was 22 months. Among 1607 patients with DSA-confirmed AVM obliteration, 16 hemorrhages (1.0%) occurred over 2223 patient-years of follow-up (0.72%/y). Of the 1543 patients with DSA-confirmed AVM obliteration, 5 AVM recurrences (0.32%) occurred over 2071 patient-years of follow-up (0.24%/y). Of the 16 patients with postobliteration hemorrhage, AVM recurrence was identified in 2 (12.5%). In the sensitivity analysis comprising 1939 patients with post-SRS AVM obliteration on magnetic resonance imaging or DSA, 16 hemorrhages (0.83%) occurred over 2560 patient-years of follow-up (0.63%/y). CONCLUSIONS: Intracranial hemorrhage and recurrent arteriovenous shunting after complete nidal obliteration are rare in AVM patients treated with SRS, and each phenomenon harbors an annual risk of <1%. Although routine postobliteration DSA cannot be recommended to SRS-treated AVM patients, long-term neuroimaging may be advisable in these patients.
- 650 _2
- $a mozek $x patologie $7 D001921
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a intrakraniální arteriovenózní malformace $x diagnostické zobrazování $x radioterapie $x chirurgie $7 D002538
- 650 _2
- $a intrakraniální krvácení $x etiologie $7 D020300
- 650 12
- $a radiochirurgie $x škodlivé účinky $7 D016634
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Ding, Dale $u Department of Neurosurgery, University of Louisville, KY (D.D., B.J.W.)
- 700 1_
- $a Kumar, Jeyan S $u Department of Neurological Surgery, University of Virginia Health System, Charlottesville (J.S.K., K.N.K., N.I., J.P.S.)
- 700 1_
- $a Kearns, Kathryn N $u Department of Neurological Surgery, University of Virginia Health System, Charlottesville (J.S.K., K.N.K., N.I., J.P.S.)
- 700 1_
- $a Ironside, Natasha $u Department of Neurological Surgery, University of Virginia Health System, Charlottesville (J.S.K., K.N.K., N.I., J.P.S.) $1 https://orcid.org/0000000293901574
- 700 1_
- $a Yang, Huai-Che $u Department of Neurosurgery, Neurological Institute, Taipei Veterans General Hospital, Taiwan (H.-C.Y., C.-C.L.) $u School of Medicine, National Yang-Ming University, Taipei, Taiwan (H.-C.Y., C.-C.L.) $1 https://orcid.org/0000000249495417
- 700 1_
- $a Ogino, Akiyoshi $u Department of Neurological Surgery, University of Pittsburgh Medical Center, PA (A.O., H.K.) $1 https://orcid.org/000000024734819X
- 700 1_
- $a Kano, Hideyuki $u Department of Neurological Surgery, University of Pittsburgh Medical Center, PA (A.O., H.K.)
- 700 1_
- $a Liscak, Roman $u Department of Neurosurgery, Na Homolce Hospital, Prague, Czech Republic (R.L., J. May)
- 700 1_
- $a May, Jaromir $u Department of Neurosurgery, Na Homolce Hospital, Prague, Czech Republic (R.L., J. May) $1 https://orcid.org/000000019925338X
- 700 1_
- $a Williams, Brian J $u Department of Neurosurgery, University of Louisville, KY (D.D., B.J.W.)
- 700 1_
- $a Gigliotti, Michael J $u Department of Neurosurgery, Penn State Health-Hershey Medical Center, Hershey, PA (M.J.G., K.C., J. McInerney, S.S.) $1 https://orcid.org/0000000181835832
- 700 1_
- $a Cockroft, Kevin $u Department of Neurosurgery, Penn State Health-Hershey Medical Center, Hershey, PA (M.J.G., K.C., J. McInerney, S.S.) $1 https://orcid.org/0000000274567507
- 700 1_
- $a McInerney, James $u Department of Neurosurgery, Penn State Health-Hershey Medical Center, Hershey, PA (M.J.G., K.C., J. McInerney, S.S.) $1 https://orcid.org/000000018071369X
- 700 1_
- $a Simon, Scott $u Department of Neurosurgery, Penn State Health-Hershey Medical Center, Hershey, PA (M.J.G., K.C., J. McInerney, S.S.)
- 700 1_
- $a Lee, Cheng-Chia $u Department of Neurosurgery, Neurological Institute, Taipei Veterans General Hospital, Taiwan (H.-C.Y., C.-C.L.) $u School of Medicine, National Yang-Ming University, Taipei, Taiwan (H.-C.Y., C.-C.L.) $1 https://orcid.org/0000000346912913
- 700 1_
- $a Sheehan, Jason P $u Department of Neurological Surgery, University of Virginia Health System, Charlottesville (J.S.K., K.N.K., N.I., J.P.S.)
- 710 2_
- $a International Radiosurgery Research Foundation
- 773 0_
- $w MED00010659 $t Stroke $x 1524-4628 $g Roč. 53, č. 8 (2022), s. e363-e368
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35616021 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20221017 $b ABA008
- 991 __
- $a 20221031101251 $b ABA008
- 999 __
- $a ok $b bmc $g 1854696 $s 1176412
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 53 $c 8 $d e363-e368 $e 20220526 $i 1524-4628 $m Stroke $n Stroke $x MED00010659
- LZP __
- $a Pubmed-20221017